First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
First results of the Phase II TITAN trial: anti-von Willebrand ... - Ablynx
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Demographic and baseline characteristics (1)<br />
• 2 men and 3 women<br />
• 3 on Nanobody treament, 2 on placebo<br />
• 4 with first episode <strong>of</strong> TTP, 1 with recurrent TTP<br />
• clinical symptoms at presentation:<br />
– 10 neurological<br />
– 4 purpura + o<strong>the</strong>r cutaneous bleeding manifestations<br />
– 2 non-cutaneous bleeding<br />
– 2 gastrointestinal<br />
– 2 cardiovascular<br />
– 1 o<strong>the</strong>r<br />
21
Change language